Author

S. F. Ahmed

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:database / resource· 1

Frequent Co-Authors

A. A. Quadeer· 3 shared M. R. McKay· 2 shared B. O. Smith· 1 shared C. Chatrin· 1 shared D. T. Huang· 1 shared E. L. Dearlove· 1 shared L. Buetow· 1 shared M. Bushell· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. A. Quadeer

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids

E. L. Dearlove, C. Chatrin, L. Buetow, S. F. Ahmed, T. Schmidt, M. Bushell, B. O. Smith, D. T. Huang

This study shows that DTX3L ubiquitinates single-stranded DNA and RNA, expanding the known substrates of ubiquitination beyond proteins.

bioRxiv · Apr 2, 2024Biochemistry

Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus

S. F. Ahmed, M. S. Sohail, A. A. Quadeer, M. R. McKay

The paper assesses cross-reactivity of vaccinia virus vaccines against new monkeypox virus variants, finding that immune responses remain highly cross-reactive.

bioRxiv · Jun 23, 2022 · PreprintImmunology

SARS-CoV-2 T cell responses are expected to remain robust against Omicron

S. F. Ahmed, A. A. Quadeer, M. McKay

The paper assesses the impact of Omicron mutations on T cell epitopes and finds that T cell responses remain broadly robust against the variant.

bioRxiv · Dec 12, 2021 · PreprintImmunology

Epitopes targeted by T cells in convalescent COVID-19 patients

A. A. Quadeer, S. F. Ahmed, M. R. McKay

This paper compiles and analyzes T cell epitopes from 15 studies of convalescent COVID-19 patients, identifying immunoprevalent epitopes and providing a web-based platform for further research.

bioRxiv · Aug 26, 2020Immunology